B. A. Koop

Split Tolerance in a Novel Transgenic Model of Autoimmune Myasthenia Gravis1

K. A. Wall, J. Windle, B. Gelb, 2002, The Journal of Immunology.

Osteoblastic cell lines derived from a transgenic mouse containing the osteocalcin promoter driving SV40 T-antigen

L. Bonewald, J. Wozney, J. Windle, 1995 .

Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice.

J. Wozney, J. Windle, N. Ghosh-Choudhury, 1996, Endocrinology.

Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice.

J. Wozney, J. Windle, G. Mundy, 1996, Endocrinology.

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice.

S. Reddy, D. Galson, N. Kurihara, 1998, The Journal of clinical investigation.

Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts.

S. Reddy, J. Windle, R. Devlin, 1995, Endocrinology.

Establishment of an Osteocyte‐like Cell Line, MLO‐Y4

L. Bonewald, J. Windle, G. Mundy, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Autoimmune Myasthenia Gravis Split Tolerance in a Novel Transgenic Model Infante and

J. Windle, B. Gelb, E. Kraig, 2002 .

Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.

S. Reddy, N. Kurihara, J. Windle, 2001, Endocrinology.

Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.

I H Wallow, G. Mangold, D. Albert, 1998, Investigative ophthalmology & visual science.